Biotechnology research and development (R&D) in Canadian industry: A portrait of large R&D performers in 1997

Technological change and innovations depend greatly on R&D activities and investments. R&D is concentrated around the "core firms" that are responsible for 87% of expenditures. Biotechnology R&D performers accounted for $904 million of R&D expenditure. Biotechnology R&D is concentrated in large firms with 75% of R&D occuring in firms with 100 or more employees. Almost 77% of funding sources for R&D in biotechnology came from the private sector and 21% from foreign sources.